Cargando…

Folic acid restricts SARS-CoV-2 invasion by methylating ACE2

The current COVID-19 pandemic is motivating us to elucidate the molecular mechanism of SARS-CoV-2 invasion and find methods for decreasing its transmissibility. We found that SARS-CoV-2 could increase the protein level of ACE2 in mice. Folic acid and 5-10-methylenetetrahydrofolate reductase (MTHFR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yuanzhou, Pang, Yechun, Xu, Baiyin, Chen, Xingshi, Liang, Shunshun, Hu, Jingying, Luo, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432853/ https://www.ncbi.nlm.nih.gov/pubmed/36060767 http://dx.doi.org/10.3389/fmicb.2022.980903

Ejemplares similares

MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer
por: Zhang, Yuanzhou, et al.
Publicado: (2022)

MiR-103a promotes tumour growth and influences glucose metabolism in hepatocellular carcinoma
por: Liu, Yuling, et al.
Publicado: (2021)

ACE2, Much More Than Just a Receptor for SARS-COV-2
por: Samavati, Lobelia, et al.
Publicado: (2020)

Altered Expression of ACE2 and Co-receptors of SARS-CoV-2 in the Gut Mucosa of the SIV Model of HIV/AIDS
por: Hu, Shuang, et al.
Publicado: (2022)

A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
por: Zhou, Xiaoyang, et al.
Publicado: (2023)

ACE2-cytomimetic particles restrict SARS-Cov-2 spike protein binding to cellular targets
por: Strong, Thomas A., et al.
Publicado: (2021)

The Possible Dual Role of the ACE2 Receptor in Asthma and Coronavirus (SARS-CoV2) Infection
por: Branco, Anna Cláudia Calvielli Castelo, et al.
Publicado: (2020)

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
por: Tarrés-Freixas, Ferran, et al.
Publicado: (2022)

Ginkgolic acids inhibit SARS-CoV-2 and its variants by blocking the spike protein/ACE2 interplay
por: Xiang, Yusen, et al.
Publicado: (2023)

ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion
por: Zhang, Qiangmin, et al.
Publicado: (2021)

Human ACE2-Functionalized Gold “Virus-Trap” Nanostructures for Accurate Capture of SARS-CoV-2 and Single-Virus SERS Detection
por: Yang, Yong, et al.
Publicado: (2021)

ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus
por: Devaux, Christian A., et al.
Publicado: (2023)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2
por: Wang, Cheng, et al.
Publicado: (2020)

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis
por: Alexpandi, Rajaiah, et al.
Publicado: (2020)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
por: Busnadiego, Idoia, et al.
Publicado: (2020)

Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication
por: Pang, Xiaocong, et al.
Publicado: (2020)

Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, E. coli Ribonuclease I and Human RNase A
por: Xu, Shuang-yong, et al.
Publicado: (2021)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

Identification of methylation signatures and rules for predicting the severity of SARS-CoV-2 infection with machine learning methods
por: Liu, Zhiyang, et al.
Publicado: (2022)

Alveolar macrophages: Achilles’ heel of SARS-CoV-2 infection
por: Wang, Zhenfeng, et al.
Publicado: (2022)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

Therapeutic Strategies for SARS-CoV-2 acting on ACE-2
por: Vitiello, A., et al.
Publicado: (2021)

Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

Oral cancer and ACE2 receptor of SARS-CoV-2
por: Martelli-Júnior, Hercílio, et al.
Publicado: (2020)

Endocrine significance of SARS-CoV-2’s Reliance on ACE2
por: Chappell, Mark C
Publicado: (2020)

ACE2, SARS-CoV-2 und RAAS-Blocker
por: Kintscher, Ulrich, et al.
Publicado: (2021)

The glycosylation in SARS-CoV-2 and its receptor ACE2
por: Gong, Yanqiu, et al.
Publicado: (2021)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

ACE2-Independent Alternative Receptors for SARS-CoV-2
por: Lim, Suhyeon, et al.
Publicado: (2022)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Drug discovery and development targeting the life cycle of SARS-CoV-2
por: Su, Haixia, et al.
Publicado: (2021)

High Expression of ACE2 on Keratinocytes Reveals Skin as a Potential Target for SARS-CoV-2
por: Xue, Xiaotong, et al.
Publicado: (2021)

SARS-CoV-2 and gastrointestinal diseases
por: Sha, Ailong, et al.
Publicado: (2023)

SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages
por: Wang, Zhenfeng, et al.
Publicado: (2022)

Mutations from bat ACE2 orthologs markedly enhance ACE2-Fc neutralization of SARS-CoV-2
por: Mou, Huihui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t943nulbue4th03n7n5g4v8tsb